Voy is a leading preventive healthcare platform for men and women, with core clinical pathways across weight management, hormone treatments, dermatology and mental health. The business is scaling fast - $675m annualised revenue, growing ~130% YoY, operating across the UK, Brazil, Germany and India.

Within Voy, the Testosterone Replacement Therapy (TRT) category is one of our fastest-growing and most strategically important lines. We're the largest private TRT provider outside the US, with 250,000+ men tested for low testosterone, a published outcomes study with Harvard Medical School covering 9,500 patients, and a clinical authority team led by Dr Jeff Foster (co-author of the UK's national testosterone guidelines). Despite that, TRT in the UK sits roughly where female HRT did a decade ago: clinically common, culturally stigmatised, and largely absent from mainstream conversation. The category is on the cusp of a cultural shift, and we intend to lead it.

We're hiring a ...